Related references
Note: Only part of the references are listed.The full spectrum of human naive T cells
Theo van den Broek et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson's Disease
Zhan Liu et al.
MOLECULAR NEUROBIOLOGY (2017)
The immune response to Prevotella bacteria in chronic inflammatory disease
Jeppe Madura Larsen
IMMUNOLOGY (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
T cells from patients with Parkinson's disease recognize α-synuclein peptides
David Sulzer et al.
NATURE (2017)
Interactions between the microbiota, immune and nervous systems in health and disease
Thomas C. Fung et al.
NATURE NEUROSCIENCE (2017)
The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis
Sen Jiang et al.
NEUROLOGICAL SCIENCES (2017)
Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments
M. von Euler Chelpin et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease
Shuchi Mittal et al.
SCIENCE (2017)
The regulation of immune tolerance by FOXP3
Ling Lu et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Transcriptional modulation of regulatory T cell development by novel regulators NR4As
Hee Yeon Won et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease
Katherine E. Olson et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Unmasking levodopa resistance in Parkinson's disease
Jorik Nonnekes et al.
MOVEMENT DISORDERS (2016)
Dopaminergic Receptors on CD4+T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease
Natasa Kustrimovic et al.
SCIENTIFIC REPORTS (2016)
Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+T-cells
Hugo Gonzalez et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice
Katherine E. Olson et al.
JOURNAL OF NEUROSCIENCE (2015)
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Benjamin Dehay et al.
LANCET NEUROLOGY (2015)
Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors
Lisa Klingelhoefer et al.
NATURE REVIEWS NEUROLOGY (2015)
Adrenergic regulation of innate immunity: a review
Angela Scanzano et al.
FRONTIERS IN PHARMACOLOGY (2015)
Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype
Filip Scheperjans et al.
MOVEMENT DISORDERS (2015)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
Hugo Gonzalez et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
The Prevalence of Parkinson's Disease: A Systematic Review and Meta-analysis
Tamara Pringsheim et al.
MOVEMENT DISORDERS (2014)
Risk of Parkinson's disease following severe constipation: A nationwide population-based cohort study
Chin-Hsien Lin et al.
PARKINSONISM & RELATED DISORDERS (2014)
Adrenergic modulation of immune cells: an update
Franca Marino et al.
AMINO ACIDS (2013)
Non-dopaminergic Treatments for Motor Control in Parkinson's Disease
Susan H. Fox
DRUGS (2013)
Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner
Marcia G. Guereschi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Immunotherapy of allergic diseases using probiotics or recombinant probiotics
M. S. P. de Azevedo et al.
JOURNAL OF APPLIED MICROBIOLOGY (2013)
Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson's Disease
Hugo Gonzalez et al.
JOURNAL OF IMMUNOLOGY (2013)
An economic model of Parkinson's disease: Implications for slowing progression in the United States
Scott J. Johnson et al.
MOVEMENT DISORDERS (2013)
The current and projected economic burden of Parkinson's disease in the United States
Stacey L. Kowal et al.
MOVEMENT DISORDERS (2013)
Transcriptional mechanisms that regulate T helper 1 cell differentiation
Kenneth J. Oestreich et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
STAT6-dependent and -independent mechanisms in Th2 polarization
Elisabeth Maier et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
CD4+Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson's Disease
Jessica A. Hutter Saunders et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Reduced T helper and B lymphocytes in Parkinson's disease
Claire H. Stevens et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Inflammation and Adaptive Immunity in Parkinson's Disease
R. Lee Mosley et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Etiology and Pathogenesis of Parkinson's Disease
Anthony H. Schapira et al.
MOVEMENT DISORDERS (2011)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Inflammation and Parkinson's Disease Pathogenesis
Serge Przedborski
MOVEMENT DISORDERS (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells
John J. O'Shea et al.
SCIENCE (2010)
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara et al.
IMMUNITY (2009)
Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2009)
GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation
I-Cheng Ho et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation
Zhi Chen et al.
SEMINARS IN IMMUNOLOGY (2007)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
Arian Laurence et al.
IMMUNITY (2007)
Interleukin-10 production by effector T cells: Th1 cells show self control
Giorgio Trinchieri
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop
Marco Cosentino et al.
BLOOD (2007)
Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation
IL Khalif et al.
DIGESTIVE AND LIVER DISEASE (2005)
Molecular pathogenesis of Parkinson disease
JL Eriksen et al.
ARCHIVES OF NEUROLOGY (2005)
Alterations of T-lymphocyte populations in Parkinson disease
Y Baba et al.
PARKINSONISM & RELATED DISORDERS (2005)
Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2004)
Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes
M Messi et al.
NATURE IMMUNOLOGY (2003)
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
J Bas et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Share Paper
